Treatment
options include surgery, radiotherapy, chemotherapy, and palliative care for end-stage disease
surgery not usually performed for SCLC since it is generally non-curable
contraindications for surgery:
spread to contralateral lymph nodes or distant sites
patients with potentially resectable disease must undergo mediastinal node sampling since CT thorax is not accurate in 20-40% of cases
poor pulmonary status (e.g. unable to tolerate resection of lung)
chemotherapy (used in combination with other treatments)
common agents: etoposide, platinum agents (e.g. cisplatinum), ifosfamide, vincristine, anthracyclines, paclitaxel, irinotecan, geftinib (an endothelial growth factor receptor inhibitor)
complications:
acute: tumour lysis syndrome, infection, bleeding, myelosuppression, hemorrhagic cystitis (cyclophosphamide), cardiotoxicity (doxorubicin), renal toxicity (cisplatin), peripheral neuropathy (vincristine)
chronic: neurologic damage, leukemia, additional primary neoplasms
Prognosis
5 yr survival rates for different subtypes:
squamous cell carcinoma 25%
adenocarcinoma 12% (60% for bronchoalveolar carcinoma, a subtype of adenocarcinoma, with a resectable solitary lesion)
large cell carcinoma 13%
SCLC 1% (poorest prognosis)
NSCLC (see Table)
Prevention
smoking cessation
avoidance of exposures
early detection
Investigations
initial diagnosis
imaging: CXR, CT chest + upper abdomen, PET scan, bone scan
cytology: sputum
biopsy: bronchoscopy, percutaneous mediastinoscopy
staging work-up
TMN staging system: T - primary tumour (size); N - regional lymph nodes; M - distant metastasis
blood work: electrolytes, LFTs, calcium, ALP
imaging: CXR, CT thorax and upper abdomen, bone scan, neuroimaging
invasive: bronchoscopy (EBUS), mediastinoscopy, mediastinotomy, thoracotomy
SCLC vs. NSCLC
Risk Factors
cigarette smoking: the relative risk of developing lung cancer is 10-30 times higher for smokers than for nonsmokers
other risk factors include cigar smoking, pipe smoking, second-hand smoke, asbestos without smoking (relative risk is 5), asbestos with smoking (relative risk is 92), metals (e.g. chromium, arsenic, nickel), radon gas, ionizing radiation, genetics
Signs and Symptoms
may be due to primary lesion, metastasis, or paraneoplastic syndrome
primary lesion:
cough (75%): beware of chronic cough that changes in character
dyspnea (60%)
chest pain (45%)
hemoptysis (35%)
other pain (25%)
clubbing (21%)
constitutional symptoms: anorexia, weight loss, fever, anemia
Metastasis
lung, hilum, mediastinum, pleura: pleural effusion, atelectasis, wheezing
pericardium: pericarditis, pericardial tamponade
esophageal compression: dysphagia
phrenic nerve: paralyzed diaphragm
recurrent laryngeal nerve: hoarseness
superior vena cava syndrome:
obstruction of SVC causing neck and facial swelling, as well as dyspnea and cough
other symptoms: hoarseness, tongue swelling, epistaxis, and hemoptysis
Px findings: dilated neck veins, increased number of collateral veins covering the anterior chest wall, cyanosis, edema of the face, arms, and chest, Pemberton’s sign (facial flushing, cyanosis, and distension of neck veins upon raising both arms above head)
milder symptoms if obstruction is above the azygos vein
lung apex (Pancoast tumours): Horner's syndrome, brachial plexus palsy (most commonly C8 and T1 nerve roots)
rib and vertebrae: erosion
distant metastasis to brain, bone, liver, adrenals
paraneoplastic syndromes
a group of disorders associated with malignant disease, not related to the physical effects of the tumour itself
Paraneoplastic Syndromes
Classification
lung tumors can be classified as primary or secondary, benign or malignant, endobronchial or parenchymal
bronchogenic carcinoma (epithelial lung tumours) are the most common type of primary lung tumor (other types make up less than 1%)
small cell lung cancer (SCLC)
non-small-cell lung cancer (NSCLC)
squamous cell carcinoma: arise from the proximal respiratory epithelium
adenocarcinoma: incidence is increasing; most common subtype in nonsmokers
bronchoalveolar carcinoma: grows along the alveolar wall in the periphery; may arise at sites of previous lung scarring
large cell undifferentiated cancer: diagnosis of exclusion
benign epithelial lung tumours can be classified as papillomas or adenomas
Characteristics of Bronchogenic Cancer